Literatur
-
1
Böthig S.
WHO
MONICA Project: Objectives and design.
Int J Epidemiol.
1989;
18
S29-S37
-
2
Chambless L, Keil U, Dobson A, Mähönen M, Kuulasmaa K, Rajakangas A M, Löwel H, Tunstall-Pedoe H. for the WHO MONICA Project .
Population versus
clinical view of case fatality from acute coronary heart disease.
Results from the WHO MONICA Project 1985 - 1990.
Circulation.
1997;
96
3849-3859
-
3 Deutsche Liga zur Bekämpfung
des hohen Blutdruckes/Deutsche Hypertonie Gesellschaft .Empfehlungen
zur Hochdruckbehandlung. Heidelberg 1999
-
4
Dobson A J, Evans A, Ferrario M. et al .
Changes in estimated coronary risk in the
1980s: data from 38 populations in the WHO MONICA Project.
Ann
Med.
1998;
30
199-205
-
5
Gregor R D, Bata I R, Eastwood B J, Wolf H K.
Ten-year trends
of heart disease risk factors in the Halifax County MONICA population.
Can
J Cardiol.
1998;
14
1017-1024
-
6
Grote L.
Antihypertensive
Medikation und Schlaf.
Dtsch Med Wschr.
1998;
123
1389-1394
-
7
Heinemann L, Barth W, Hoffmeister H.
Trend
of cardiovascular risk factors in the East German population 1968 - 1992.
J
Clin Epidemiol.
1995;
48
787-795
-
8
Heinemann L AJ, Garbe E, Claßen E, Willich S N, Barth W, Thiel C.
Trends im kardiovaskulären
Risikofaktorenprofil in Ostdeutschland. Drei unabhängige
Bevölkerungsuntersuchungen im Rahmen des Projekts MONICA
Ostdeutschland.
Dtsch Med Wschr.
1998;
123
889-895
-
9
Hense H W, Filipiak B, Döring A, Stieber J, Liese A, Keil U.
Ten-year trends of cardiovascular
risk factors in the MONICA Augsburg region in Southern Germany.
Results from the 1984/85, 1989/90, and 1994/95
surveys.
CVD Prevention.
1999;
1
318-327
-
10
Hense H W, Gneiting B, Muscholl M, Broeckel U, Kuch B, Döring A, Riegger G AJ, Schunkert H.
The associations of
body size and body composition with left ventricular mass: Impacts
for indexation in adults.
J Am Coll Cardiol.
1998;
32
451-457
-
11
Hense H W, Koivisto A M, Kuulasmaa K. et al .
Assessment of blood pressure measurement
quality in the baseline surveys of the WHO MONICA Project.
J
Hum Hypertens.
1995;
9
935-946
-
12
Hoffmeister H, Mensink G B, Stolzenberg H.
National
trends in risk factors for cardiovascular disease in Germany.
Prev
Med.
1994;
23
197-205
-
13
Jackson R, Barham P, Bills J, Birch T, McLennan L, MacMahon S, Maling T.
Management of raised
blood pressure in New Zealand: A discussion document.
BMJ.
1993;
307
107-110
-
14
Joint National Committee .
The
6th Report of the Joint National Committee on prevention, detection,
evaluation, and treatment of high blood pressure.
Arch
Intern Med.
1997;
157
2413-2446
-
15
Julius S, Valentini M, Palatini P.
Overweight
and hypertension. A 2-way street?.
Hypertension.
2000;
35
807-813
-
16
Keil U, Liese A D, Hense H W, Filipiak B, Döring A, Stieber J, Löwel H.
Classical risk
factors and their impact on incident non-fatal and fatal myocardial
infarction and all-cause mortality in southern Germany. Results
from the MONICA Augsburg Cohort Study 1984 - 1992.
Eur Heart
J.
1998;
19
1197-1207
-
17
Kolloch E, Rahn K H.
Die »Hypertension
Optimal Treatment«(HOT)-Studie. Behandlungsergebnisse nach
zwölfmonatiger Therapie in Abhängigkeit vom Alter.
Dtsch
Med Wschr.
1998;
123
1-5
-
18
Kroke A, Liese A, Keil U, Boeing H.
Arterial
hypertension and glycemia in non-diabetic subjects.
Diabetes
Metab Res Rev.
1999;
15
99-105
-
19
Kuch B, Muscholl M, Luchner A, Doring A, Riegger G A, Schunkert H, Hense H W.
Geschlechtsunterschiede
in der Beziehung zwischen Übergewicht und Hypertonie mit
linksventrikulärer Masse und Hypertrophie.
Z
Kardiol.
1996;
85
334-342
-
20
Levy D, Garrison R J, Savage D D, Kannel W B, Castelli W P.
Prognostic
implications of echocardiographically determined left ventricular
mass in the Framingham Heart Study.
N Engl J Med.
1990;
322
1561-1566
-
21
Liese A D, Mayer-Davis E J, Haffner S M.
Development
of the multiple metabolic syndrome.
Epidemiol Rev.
1998;
20
157-172
-
22
Löwel H, Lewis M, Keil U, Hörmann A, Bolte H D, Willich S, Gostomzyk J.
Zeitliche Trends von
Herzinfarktmorbidität, -mortalität, 28-Tage-Letalität
und medizinischer Versorgung.
Z Kardiol.
1995;
84
596-605
-
23
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J.
Blood
pressure, stroke, and coronary heart disease. Part 1, Prolonged
differences in blood pressure.
Lancet.
1990;
335
765-774
-
24
Manolio T A, Cutler J A, Furberg C D, Psaty B M, Whelton P K, Applegate W B.
Trends in
pharmacologic management of hypertension in the United States.
Arch
Intern Med.
1995;
155
829-837
-
25
Nelson R G, Knowler W C, Pettitt D J, Saad M F, Charles M A, Bennett P H.
Assessment
of risk of overt nephropathy in diabetic patients from albumin excretion
in untimed urine specimens.
Arch Intern Med.
1991;
151
1761-1765
-
26
Nieto F J, Alonso J, Chambless L E, Zhong M, Ceraso M, Romm F J, Cooper L, Folsom A R, Szklo M.
Population awareness and
control of hypertension and hypercholesterolemia. The Atherosclerosis
Risk in Communities Study.
Arch Intern Med.
1995;
155
677-684
-
27
Reaven G M.
Role
of insulin resistance in human disease.
Diabetes.
1988;
37
1595-1607
-
28
Rocella E J, Burt V, Horan M J, Cutler J.
Changes in hypertension
awareness, treatment, and control rates.
Ann Epidemiol.
1993;
3
547-549
-
29
Sans S, Kesteloot H, Kromhout D.
The burden of cardiovascular
diseases mortality in Europe. Task Force of the European Society
of Cardiology on Cardiovascular Mortality and Morbidity Statistics
in Europe.
Eur Heart J.
1997;
18
1231-1248
-
30
Savage D D, Levy D, Dannenberg A L, Garrison R J, Castelli W P.
Association
of echocardiographic left ventricular mass with body size, blood pressure
and physical activity (the Framingham Study).
Am J Cardiol.
1990;
65
371-376
-
31
Schäfers R F, Lütkes P, Ritz E, Philipp Th.
Leitlinie zur Behandlung
der arteriellen Hypertonie bei Diabetes mellitus - Konsensus-Empfehlungen
der Deutschen Liga zur Bekämpfung des hohen Blutdruckes
e. V., der Deutschen Diabetes Gesellschaft und der Gesellschaft
für Nephrologie.
Dtsch Med Wschr.
1999;
124
1356-1372
-
32
Sharma A M, Möller T, Engeli S.
Hypertonie
bei Adipositas: Epidemiologie, Pathophysiologie und Behandlungsansätze.
Dtsch
Med Wschr.
1999;
124
1337-1341
-
33
Schunkert H, Broeckel U, Hengstenberg C, Luchner A, Muscholl M, Kurzidim K, Kuch B, Döring A, Riegger G AJ, Hense H W.
Familial predisposition
of left ventricular hypertophy.
J Am Coll Cardiol.
1999;
33
1685-1691
-
34
Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. for the WHO MONICA Project .
Contribution
of trends in survival and coronary-event rates to changes in coronary
heart disease mortality: 10-year results from 37 WHO MONICA Project
populations.
Lancet.
1999;
353
1547-1557
-
35
Vartiainen E, Puska P. et al .
Twenty-year
trends in coronary risk factors in North Karelia and in other areas
of Finland.
Int J Epidemiol.
1994;
23
495-504
-
36
. WHO MONICA Project
Principal Investigators .
The World Health Organization
MONICA Project: A major international collaboration.
J Clin
Epidemiol.
1988;
41
105-114
-
37
Wietlisbach V, Paccaud F, Rickenbach M, Gutzwiller F.
Trends in cardiovascular
risk factors 1984-1993 in a Swiss region: Results of three population
surveys.
Prev Med.
1997;
26
523-533
-
38
Wilhelmsen L, Johansson S, Rosengren A. et al .
Risk factors for cardiovascular disease
during the epriod 1985 - 1995 in Goteborg,
Sweden. The GOT-MONICA Project.
J Intern Med.
1997;
242
199-211
-
39
Wilson P W, DAgostino R B, Levy D. et al .
Prediction of coronary heart disease using
risk factor categories.
Circulation.
1998;
97
1837-1847
-
40
Wood D, De
Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. together with members of the Task Force .
Prevention
of coronary heart disease in clinical practice. Recommendations
of the Second Joint Task Force of European and other Societies on
Coronary Prevention.
Eur Heart J.
1998;
19
1434-1503
Prof. Dr. med. Hans-Werner Hense
Institut für Epidemiologie und Sozialmedizin -
Bereich Klinische Epidemiologie - Westfälische
Wilhelms-Universität Münster
Domagkstraße 3
48129 Münster
Phone: 0251/8355399
Fax: 0251/8355300
Email: hense@uni-muenster.de
